
Back Bay Life Science Report
by Jonathan P. Gertler and Peter Bak
November 9, 2024 12:53 am
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, strategic, and financial analysis at the intersection of science and business.
Recent Episodes
The Optimism of Bispecific Antibodies
1 week ago00:00/00:00Dynamics in Healthcare Focused Markets
2 months ago00:00/00:00From NASH to MASH: Current Market Dynamics in Hepatology
2 months ago00:00/00:00Key Considerations for a US Healthcare IPO
6 months ago00:00/00:00Drug Development in Obesity
7 months ago00:00/00:00The Current Dynamics in Capital Markets
7 months ago00:00/00:00Vaccine Developments 2024: A Podcast Discussion on Latest Vaccine Technology and Ongoing Clinical Developments
8 months ago00:00/00:00Trends and Investment Activity in Radiopharmaceuticals and Psychedelics
9 months ago00:00/00:00Vertex’s Exa-cel to Biogen and Sage’s Zurzuvae: Notable Product Approvals of 2023
11 months ago00:00/00:00Monthly Roundup of News from Healthcare Development
1 year ago00:00/00:00